[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336071-105":59,"doc-detail-336071-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","investigating-the-mechanisms-of-drug-resistance-and-prognosis-in-ovarian-cancer-using-single-cell-rna-sequencing-and-bulk-rna-sequencing","Investigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing","","Ovarian cancer is a prevalent gynecologic malignancy, and chemotherapy resistance remains a major barrier to improved outcomes. A single-cell study examines drug resistance and mitotic activity in core tumor cells, mapping interrelationships and temporal trajectories of distinct epithelial cell subpopulations while linking genes to patient prognosis. Results associate epithelial-cell drug resistance with oxidative phosphorylation pathways. Subpopulation and trajectory analyses identify intermediate EPC subpopulation C0, and characterize its immunological functions and differentially expressed genes to support novel prognostic models and therapeutic target discovery.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/investigating-the-mechanisms-of-drug-resistance-and-prognosis-in-ovarian-cancer-using-single-cell-rna-sequencing-and-bulk-rna-sequencing/336071/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/investigating-the-mechanisms-of-drug-resistance-and-prognosis-in-ovarian-cancer-using-single-cell-rna-sequencing-and-bulk-rna-sequencing/336071.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What study approach is used to investigate ovarian cancer drug resistance and prognosis?","Question",{"text":112,"@type":113},"The research uses single-cell RNA sequencing together with bulk RNA sequencing to analyze tumor cell resistance mechanisms and prognosis-related genes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which pathway is linked to drug resistance in epithelial cell subpopulations?",{"text":117,"@type":113},"The findings establish a strong association between epithelial cell drug resistance and oxidative phosphorylation pathways.",{"name":119,"@type":110,"acceptedAnswer":120},"How is subpopulation C0 involved in prognosis and potential model building?",{"text":121,"@type":113},"Subpopulation and trajectory analyses confirm the intermediate position of EPC subpopulation C0, whose immunological functions and differentially expressed genes are tied to prognosis, supporting new prognostic model construction and therapeutic target identification.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336071,1790167842,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":81,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 5  \nResearch Paper  \nInvestigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing  \nPengfei Liu1, Jinbao Liu1, Jinxing Liu1, Xiao Yu2  \n1Shandong University of Traditional Chinese Medicine, Jinan, China  \n2Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China  \nCorrespondence to: Xiao Yu; [email:](email: yuxiao20230316@163.com)[ ](email: yuxiao20230316@163.com)[yuxiao20230316@163.com](email: yuxiao20230316@163.com), [https://orcid.org/0009-0005-5025-2438](https://orcid.org/0009-0005-5025-2438)[ ](https://orcid.org/0009-0005-5025-2438)[Keywords:](Keywords: ovarian cancer)[ ovarian cancer](Keywords: ovarian cancer), single-cell RNA sequencing, bulk RNA sequencing, resistance, prognosis  \nReceived: October 16, 2023 Accepted: February 2, 2024 Published: March 8, 2024  \nCopyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nOvarian cancer stands as a prevalent malignancy within the realm of gynecology, and the emergence of resistance to chemotherapeutic agents remains a pivotal impediment to both prognosis and treatment. Through a single-cell level investigation, we scrutinize the drug resistance and mitotic activity of the core tumor cells in ovarian cancer. Our study revisits the interrelationships and temporal trajectories of distinct epithelial cells (EPCs) subpopulations, while identifying genes associated with ovarian cancer prognosis. Notably, our findings establish a strong association between the drug resistance of EPCs and oxidative phosphorylation pathways. Subsequently, through subpopulation and temporal trajectory analysis, we confirm the intermediate position of EPCs subpopulation C0 . Furthermore, we delve into the immunological functions and differentially expressed genes associated with the prognosis of C0, shedding light on the potential for constructing novel ovarian cancer prognosis models and identifying new therapeutic targets.  \nINTRODUCTION  \nOvarian cancer has exhibited a rising incidence globally in recent years, ranking as the most common and highly aggressive malignancy among gynecological tumors [1, 2] . Due to the lack of distinctive early symptoms, early detection through non-invasive means is challenging, resulting in a diagnosis at an advanced stage in up to 70% of ovarian cancer patients [3, 4] . According to global cancer statistics from 2020, there were 313,959 newly diagnosed cases of ovarian cancer worldwide, with 207,252 ovarian cancer-related deaths reported [5] . BRCA1 and BRCA2 stand out as widely recognized genetic susceptibility genes for ovarian cancer. Mutations in BRCA genes escalate the hereditary risk of ovarian cancer. Studies have indicated that females with mutations in the BRCA1 gene face a 3 to 4 times higher risk of developing ovarian cancer compared to those with mutations in the BRCA2 gene  \n[6] . Like many cancer treatment modalities, surgery and chemotherapy are commonly employed in ovarian cancer management. However, the associated side effects and diminished quality of life often pose significant challenges for patients [7] . Furthermore, the high recurrence rates and development of drug resistance contribute to a 5-year survival rate of only approximately 47% for ovarian cancer patients [8] . Research has revealed that although most ovarian cancer patients initially respond to platinum-based chemotherapy, approximately 70-80% of patients eventually relapse and develop resistance, with the situation worsening over time [9–12] . In fact, the 5-year survival rate for advanced-stage high-grade serous ovarian cancer can be as low as 26%[13] . Presently, while neoadjuvant chem","cbCaimVzAt0FkwAe","https://ap.wps.com/l/cbCaimVzAt0FkwAe","pdf",6590681,23,"English","# Abstract\n# Introduction","[{\"question\":\"What study approach is used to investigate ovarian cancer drug resistance and prognosis?\",\"answer\":\"The research uses single-cell RNA sequencing together with bulk RNA sequencing to analyze tumor cell resistance mechanisms and prognosis-related genes.\"},{\"question\":\"Which pathway is linked to drug resistance in epithelial cell subpopulations?\",\"answer\":\"The findings establish a strong association between epithelial cell drug resistance and oxidative phosphorylation pathways.\"},{\"question\":\"How is subpopulation C0 involved in prognosis and potential model building?\",\"answer\":\"Subpopulation and trajectory analyses confirm the intermediate position of EPC subpopulation C0, whose immunological functions and differentially expressed genes are tied to prognosis, supporting new prognostic model construction and therapeutic target identification.\"}]","Investigating the mechanisms of drug resistance and prognosis in ovarian cancer using single-cell RNA sequencing and bulk RNA sequencing | PDF",1790013519,58,[147,151,155],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/8cdf0f0bd5d7662b7a7d5077925b6538.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/e369426cd104c8b7f0ae72f71bbdfd6b.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/7f00aa076731b0ce9ac9418eacb9814c.webp",981,1269]